Marine Bio (MBII) Misses Q4 EPS by 6c

Marine Bio (NASDAQ: MBII) reported Q4 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.63 million versus the consensus estimate of $3.53 million.

Recent and 2016 Business Highlights

• Row Crop Collaborations with Koch Agronomic Services and Albaugh LLC
• Majestene Bionematicide Launched and Awarded “Best New Biopesticide” by Agrow
• Successful Launches of New Regalia and Grandevo Formulations
• Haven Anti-Transpirant Now Commercially Available
• EPA Registration of MBI-601 Biofumigant
• Regalia Registration in Chile
• First Commercial Grandevo sales in Mexico
• Execution of Grandevo Distribution Agreement for Australia and New Zealand
• Advanced Insecticidal Product Candidate under Evogene Collaboration

Field Trial Highlights

• Regalia showed increased yields in strawberries, rice, alfalfa and tomato and improved coffee rust control in Central America.
• Majestene demonstrated efficacy against nematodes and growth, yield or quality increases demonstrated in thirteen different crops.
• Grandevo confirmed its performance for the serious and invasive spotted wing Drosophila on soft fruits, especially in rotations with conventional standards for resistance management.
• Venerate performed as well as two chemical standards against walnut husk fly and showed promise in programs for Asian citrus psyllid, strawberry thrips and coffee berry borer.
• Haven demonstrated increased yields for almonds, walnuts, tomatoes and corn and reduction of sun stress and bitter pit in certain apple varieties.
• Biostacked seed treatments developed in conjunction with Groundwork BioAg, Ltd showed significant corn and soy yield increases comparable to commercial chemical and mixed chemical and biological standards for key nematode and corn rootworm pests.

For earnings history and earnings-related data on Marine Bio (MBII) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04